* Apollo Medical Holdings Inc is expected to show a rise in quarterly revenue when it reports results on February 27 for the period ending December 31 2023

* The Alhambra California-based company is expected to report a 15.8% increase in revenue to $340.612 million from $294.21 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

* ​LSEG's mean analyst estimate for Apollo Medical Holdings Inc is for earnings of 15 cents per share.

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Apollo Medical Holdings Inc is $45.00​, above​ its last closing price of $40.82. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Sep. 30 2023 0.31 0.33 0.47 Beat 42.4

Jun. 30 2023 0.25 0.25 0.28 Beat 12

Mar. 31 2023 0.31 0.31 0.31 Met 1.1​

Dec. 31 2022 -0.11 -0.09 -0.06 Beat 33.3

​​Sep. 0.31 0.32 0.56 Beat 75.8

30 2022

Jun. 30 2022 0.20 0.20 0.25 Beat 23.2​

Mar. 31 2022 0.32 0.32 0.31 Missed -3.1

Dec. 31 2021 0.26 0.27 0.30 Beat 13.2

This summary was machine generated February 24 at 02:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)